Equine metabolic syndrome (EMS) is characterized by abnormal insulin regulation, obesity and susceptibility to laminitis. EMS is challenging to diagnose since laboratory tests fail to distinguish EMS from other common equine diseases. Human metabolic syndrome (HMS) shares similar laboratory features to EMS and a new serum biomarker has been proposed in human medicine to improve the diagnosis of HMS. Researchers will investigate if this new HMS test also can provide an accurate diagnosis for horses with EMS. A new efficient and cost-effective EMS test will help veterinarians better diagnose and manage this complex disease in horses.
Grant amount awarded
Gabriele Rossi, DVM, PhD, DECVCP
Endocrine/Metabolic (Diabetes, Thyroid)